1Talbot EM.Dangers of adding insulin to intravenous infusion bags with fixed needle syringes[J].Br Med J,1984,28(9):678-680.
2Bengman Nk Vellar.ID potential life-threatening variation of drug concentrations in intravenous infusion systems[J].Med Aust,1982,36(2):270-272.
3Alberti KG.Diabetic emergencies[J].Br Med Bull,1989,45(1):242-263.
4Trissel LA.Handbook on injectable drugs[M].Sth Ed.Bethesda MD:American Society of Health -System pharmacists,1994.584-590.
5Amann AH,Baaske DM.The loss of nitroglycerin from intravenous administration sets during infusion:A therotical treatment[J].J Rharm Sci,1982,71(4): 473-474.
6Sattler A,Jage J,Kramer I.Physico-chemical stability of infusion solution for epidural administration containing fentanyl and bupivacaine or lidocaine[J].Pharmazie,1998,53(6):386.
7Shibsys N,lkrno Y,Tsubakimoto Y,et al.Absorption and pharmacokinetics of cyclosporin A in relation to mode of infusion in bone marrow transplant patients[J].Bone Marrow Transplant,2000,25(6):633.
8Loucas SP,Maager P,Mehl B,et al.Effect of vechicle ionic strength on sorption of nirroglycerin to a polyvinyl chloride administration set [J].Am J Hosp Pharm,1990,47(15):59-62.
9t3eitz C, t3ertsch T, Hannak D, et al. Compatibility of plastics with cytotoxic drug solutions- comparison of polyethylene with other container materials[J] . Int J Pharm , 1999,185(1) : 113.
10Sarsfield BA, Maloy JT. Short- term chronamperometric screening of chlorpromazine- package interactions[J ].J Pharm Sci, 1998,87:78.
